Cargando…
Paying Americans to take the vaccine—would it help or backfire?
This research investigates the extent to which financial incentives (conditional cash transfers) would induce Americans to opt for vaccination against coronavirus disease of 2019. We performed a randomized survey experiment with a representative sample of 1000 American adults in December 2020. Respo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420956/ https://www.ncbi.nlm.nih.gov/pubmed/34512996 http://dx.doi.org/10.1093/jlb/lsab027 |
_version_ | 1783748980509769728 |
---|---|
author | Robertson, Christopher Scheitrum, Daniel Schaefer, Aleks Malone, Trey McFadden, Brandon R Messer, Kent D Ferraro, Paul J |
author_facet | Robertson, Christopher Scheitrum, Daniel Schaefer, Aleks Malone, Trey McFadden, Brandon R Messer, Kent D Ferraro, Paul J |
author_sort | Robertson, Christopher |
collection | PubMed |
description | This research investigates the extent to which financial incentives (conditional cash transfers) would induce Americans to opt for vaccination against coronavirus disease of 2019. We performed a randomized survey experiment with a representative sample of 1000 American adults in December 2020. Respondents were asked whether they would opt for vaccination under one of three incentive conditions ($1000, $1500, or $2000 financial incentive) or a no-incentive condition. We find that—without coupled financial incentives—only 58 per cent of survey respondents would elect for vaccination. A coupled financial incentive yields an 8-percentage-point increase in vaccine uptake relative to this baseline. The size of the cash transfer does not dramatically affect uptake rates. However, incentive responses differ dramatically by demographic group. Republicans were less responsive to financial incentives than the general population. For Black and Latino Americans especially, very large financial incentives may be counter-productive. |
format | Online Article Text |
id | pubmed-8420956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-84209562021-09-09 Paying Americans to take the vaccine—would it help or backfire? Robertson, Christopher Scheitrum, Daniel Schaefer, Aleks Malone, Trey McFadden, Brandon R Messer, Kent D Ferraro, Paul J J Law Biosci Essay This research investigates the extent to which financial incentives (conditional cash transfers) would induce Americans to opt for vaccination against coronavirus disease of 2019. We performed a randomized survey experiment with a representative sample of 1000 American adults in December 2020. Respondents were asked whether they would opt for vaccination under one of three incentive conditions ($1000, $1500, or $2000 financial incentive) or a no-incentive condition. We find that—without coupled financial incentives—only 58 per cent of survey respondents would elect for vaccination. A coupled financial incentive yields an 8-percentage-point increase in vaccine uptake relative to this baseline. The size of the cash transfer does not dramatically affect uptake rates. However, incentive responses differ dramatically by demographic group. Republicans were less responsive to financial incentives than the general population. For Black and Latino Americans especially, very large financial incentives may be counter-productive. Oxford University Press 2021-09-06 /pmc/articles/PMC8420956/ /pubmed/34512996 http://dx.doi.org/10.1093/jlb/lsab027 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Duke University School of Law, Harvard Law School, Oxford University Press, and Stanford Law School. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Essay Robertson, Christopher Scheitrum, Daniel Schaefer, Aleks Malone, Trey McFadden, Brandon R Messer, Kent D Ferraro, Paul J Paying Americans to take the vaccine—would it help or backfire? |
title | Paying Americans to take the vaccine—would it help or backfire? |
title_full | Paying Americans to take the vaccine—would it help or backfire? |
title_fullStr | Paying Americans to take the vaccine—would it help or backfire? |
title_full_unstemmed | Paying Americans to take the vaccine—would it help or backfire? |
title_short | Paying Americans to take the vaccine—would it help or backfire? |
title_sort | paying americans to take the vaccine—would it help or backfire? |
topic | Essay |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420956/ https://www.ncbi.nlm.nih.gov/pubmed/34512996 http://dx.doi.org/10.1093/jlb/lsab027 |
work_keys_str_mv | AT robertsonchristopher payingamericanstotakethevaccinewouldithelporbackfire AT scheitrumdaniel payingamericanstotakethevaccinewouldithelporbackfire AT schaeferaleks payingamericanstotakethevaccinewouldithelporbackfire AT malonetrey payingamericanstotakethevaccinewouldithelporbackfire AT mcfaddenbrandonr payingamericanstotakethevaccinewouldithelporbackfire AT messerkentd payingamericanstotakethevaccinewouldithelporbackfire AT ferraropaulj payingamericanstotakethevaccinewouldithelporbackfire |